Cresco Labs (CRLBF) EBT Margin (2020 - 2026)

Cresco Labs (CRLBF) posted EBT Margin of 1.85% for Q1 2026, up 96.58% on a QoQ basis from 53.94% in Q4 2025, and down 129.0% year-over-year from 6.37% in Q1 2025.

Cresco Labs (CRLBF) EBT Margin (2020 - 2026) Analysis & Trends

Cresco Labs' EBT Margin history runs 7 years deep, the most recent figure standing at 1.85% for Q1 2026.

  • Quarterly EBT Margin fell 129.0% year-over-year to 1.85% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 15.17% (down 1128.0% YoY) and the FY2025 annual result came in at 14.55%, down 1308.0% from the prior year.
  • EBT Margin was 1.85% for Q1 2026 at Cresco Labs, up from 53.94% in the prior quarter.
  • Across five years, EBT Margin topped out at 8.65% in Q1 2024 and bottomed at 78.6% in Q4 2022.
  • A 5-year average of 12.19% and a median of 0.55% in 2025 frame the typical range for EBT Margin.
  • Peak annual rise in EBT Margin reached 16851 bps in 2022, while the deepest fall reached 8393 bps in 2022.
  • Cresco Labs' EBT Margin stood at 78.6% in 2022, then surged by 109 bps to 6.81% in 2023, then sank by 74 bps to 1.74% in 2024, then sank by 3206 bps to 53.94% in 2025, then surged by 97 bps to 1.85% in 2026.
  • Business Quant data shows CRLBF's EBT Margin at 1.85% in Q1 2026, 53.94% in Q4 2025, and 6.13% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 10.97%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 33.51%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -41.57%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 40.73%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -7.05%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 30.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.35%
10 Cresco Labs 254.96 Mn 99.57 Mn 75.45 Mn -1.85%

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.85%
Dec 31, 2025 -53.94%
Sep 30, 2025 -6.13%
Jun 30, 2025 1.68%
Mar 31, 2025 -0.55%
Dec 31, 2024 1.74%
Sep 30, 2024 6.30%
Jun 30, 2024 -22.21%
Mar 31, 2024 8.65%
Dec 31, 2023 6.81%
Sep 30, 2023 -62.55%
Jun 30, 2023 -14.92%
Mar 31, 2023 -5.67%
Dec 31, 2022 -78.60%
Sep 30, 2022 7.36%
Jun 30, 2022 7.03%
Mar 31, 2022 -0.40%
Dec 31, 2021 5.33%
Sep 30, 2021 -161.15%
Jun 30, 2021 7.68%